Requip XL - (2, 3, 4, 6, 8, 12 mg; Tablet, Extended Release)

Generic Name	Ropinirole Hydrochloride	Innovator	GlaxoSmithkline
Dosage	2, 3, 4, 6, 8, 12 mg; Tablet, Extended Release	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	None	Tentative Approvals	None
Final Approvals	More Than 5	Generic Launches	Less Than 5
Indication	Used to treat Parkinson's disease
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
** *****'*	*** \ ***	**	*** *********	********	******** ** *** *, ****
*******	** \ **	**	*** *********	********	******** ** *** **, ****
******	** \ **	**	*** *********	********	******** ** *** *, ****

Chronology Of Events